In the last two decades, it has become clear that cd T cells recognize a diverse array of antigens including self and foreign, large and small, and peptidic and non-peptidic molecules. In this respect, cd antigens as a whole resemble more the antigens recognized by antibodies than those recognized by ab T cells. Because of this antigenic diversity, no single mechanism-such as the major histocompatibility complex (MHC) restriction of ab T cells-is likely to provide a basis for all observed T-cell antigen receptor (TCR)-dependent cd T-cell responses. Furthermore, available evidence suggests that many individual cd T cells are poly-specific, probably using different modes of ligand recognition in their responses to unrelated antigens. While posing a unique challenge in the maintenance of self-tolerance, this broad reactivity pattern might enable multiple overlapping uses of cd T-cell populations, and thus generate a more efficient immune response.
INTRODUCTION
Determining which antigens (Ags) cd T cells recognize with their Tcell antigen receptors (TCRs) arguably remains the biggest challenge in the field. Significant progress has been made during the last several years in collecting individual examples of Ag responses of cd T cells and, in some cases, in delineating the mechanism of Ag recognition. The upshot of these studies is that cd T cells recognize diverse Ags, quite different from the uniform, major histocompatibility complex (MHC)-packaged protein fragments recognized by ab T cells, and more like the highly variable and diverse Ags recognized by B cells (Figure 1 ). This observation, along with a structural comparison of the cd TCRs with immunoglobulins, encouraged the hypothesis that ligand recognition by cd T cells is B cell-like. 1 However, despite obvious similarities, the cd TCRs are different from the B-cell receptors (BCRs) in structure and composition, and chances are that Ag recognition by cd T cells is a unique feature of this lymphocyte type, even if it resembles in some aspects Ag recognition by other lymphocytes. In this review, we will examine the diversity of Ags recognized by cd T cells, as well as cellular distributions of cd specificities, and possible consequences for self-tolerance in comparison with ab T cells and B cells.
THE cd T-CELL RECEPTORS
The cd TCRs are encoded by two distinct sets of genes, c and d, which rearrange like the Ig genes to form templates for diverse TCR protein molecules. 2 Although there are fewer Vc and Vd genes than IgV and TCRabV genes, the recombinatorial possibilities for generating the cd TCRs are almost infinite, 3 largely due to the unique ability of the d genes to rearrange D segments in tandem and to utilize all three reading frames. This creates multiple joints in the same single gene, each with the opportunity for N region additions and trimming. However, this unique mechanism focuses potential cd TCR diversity on a relatively small region of the TCR surface, CDR3d. The significance of this narrow focus is not yet clear as will be further discussed below. Despite the potential for diversity, some commonly occurring cd TCRs are invariant, 4 or nearly invariant, which has led to the concept of cd TCRs as innate pattern recognition receptors. However, other cd TCRs are diverse initially, and later selected during immune responses. 5, 6 At the level of lymphocyte populations, the cd TCRs appear to be less evenly distributed than the other adaptive receptors. In mice, where this has been studied in detail, subsets of cd T cells expressing different Vcs become segregated already during ontogeny due to their sequential developmental patterns in the thymus. 7 This temporal segregation may also dictate their spacial partition, as cells expressing different Vcs colonize different peripheral tissues. 2 cd T cells expressing different Vcs have different effects on the immune responses. 8 Recent studies revealed a correlation between TCR-Vc expression and functional differentiation, 9, 10 thus emphasizing the biological significance of the cd TCR segregation in the mouse. Nevertheless, specific evidence concerned with IL-17 producing cd T cells suggests that, at least in this case, the correlation between cd TCR expression and function is merely coincidental-waves of cd T cells expressing certain TCRs coincide with a thymic environment that temporarily favors TH17 differentiation. 11 Although there is still less experimental evidence, segregation of TCR-defined cd T-cell subsets (both spacial and functional) has also been found in other species and might well be a universal feature of these cells. With regard to Ag specificity, one immediate consequence of this is a partial repertoire restriction, and the association of certain repertoires with certain functions. This might be necessary in maintaining self-tolerance, or to channel the responses of cd T cells into patterns with predetermined outcomes. In any case, it suggests a degree of rigidity of the repertoire that seems to be absent in B cells. Along the same vein, there is no evidence of somatic mutation in the cd TCRs. Therefore, any affinity maturation of cd T cells has to be driven by CDR3 selection, although cd TCRligand interactions described so far are low affinity by comparison with class-switched BCRs. On the other hand, ligand recognition by cd T cells is not limited to MHC-presented peptides. Affinities of TCR-ligand interactions seem to vary considerably, and in some reported cases were of higher affinity than those of MHC-restricted ab TCRs. In this regard and by comparison with ab T cells at least, the cd responses show more variation and plasticity. 12 The density of cell surface-expressed cd TCRs is generally similar to that of ab TCRs, but there are differences between the two types of TCR in terms of their association with proteins of the CD3 complex. Of note, murine cd TCR complexes lack CD3d, and upon activation instead express FceR1c, in contrast to the ab TCRs and to human cd TCRs. 13 At least some of the cd TCRs appear to signal more efficiently than the ab TCRs, which is described in detail elsewhere. 13, 14 This might lower the activation threshold for certain cd T cells. Nevertheless, the cd TCRs overall resemble the other cell surfaceexpressed adaptive lymphocyte receptors, the BCRs and the ab TCRs, suggesting that they provide similar sensitivities to the lymphocytes that carry them.
MECHANISM OF LIGAND RECOGNITION
We already mentioned the hypothesis, proposed by Chien and collaborators, 1 that ligand recognition by cd T cells is B cell-like. This idea is based on structural and functional observations. Thus, CDR3 regions of the cd TCRs resemble Ig CDRs in terms of length and variability. 15 As is the case with Ig heavy and light chains, respectively, TCR-d has extensive CDR3s whereas TCR-c has short CDR3s. Moreover, TCR-d CDR3s are far more diverse, similar to IgH CDR3s. In contrast, TCR-a and TCR-b CDR3s are intermediate in length, and similar to each other both in length and diversity, which may be a requirement for the docking on the surface of MHC molecules and the recognition of MHC-bound small peptides. However, with cd TCRs, most of the potential for diversity is concentrated in CDR3d, while BCRs are diverse in CDR1 and 2 as well, and have, in addition, the option of affinity maturation through somatic mutation, which implies large differences in ligand recognition. Not only will B cells recognize a wider array of ligands, but also will they interact with them through higher affinity.
Other observations support the idea of B cell-like ligand recognition by cd T cells, but they also illustrate differences. Thus, there is a conspicuous absence of reports of MHC-restricted Ag recognition by cd T cells, 16 which is the main mode of ligand recognition by ab T cells. Possible exceptions to this observation will be discussed below. However, in some cases it has been shown that Ags must be presented to be stimulatory for cd T cells. 17 These presented Ags tend to be small, and in soluble form might not be capable of TCR cross-linking, a prerequisite for activation via immunoreceptors. Whether any Ags in solution can be recognized and can trigger responses of cd T cells is not yet known, although this seems likely when such Ags are multivalent. 18 An example might be the response to an insulin peptide, which can be elicited from isolated single hybridoma cells (in the absence of antigen-presenting cells (APCs) or other hybridoma cells) expressing an insulin peptide-reactive cd TCR. 19 Whether responses to cell surface-expressed molecules such as CD1c, CD1d, MICA/B and T10/22 have a special significance in cd TCR-mediated ligand recognition remains unclear. Unlike the ab TCRs, which have an inherent bias for MHC recognition associated with certain dedicated amino acids, 20, 21 no such bias has been reported for the cd TCRs. In fact, judging from the interaction of T10/22-reactive cd TCRs with their ligand, where specificity is largely determined by a single D segment within TCR-d, 22 there is no reason to expect a similar bias for the cd TCRs. Similarly, no inherent MHC bias seems to exist with the BCRs. However, it remains possible that cd TCRs have inherent biases for the recognition of cell surface molecules other than MHC, 23 and given the limitation of the repertoire outside of CDR3d, this even seems likely. 24 No such bias or restricting element has been firmly established, however. Perhaps the biggest difference to Ag recognition via BCRs is that so many conventional Ags seem to be incapable of eliciting responses by cd T cells. To our knowledge, specific TCR-mediated responses of cd T cells have not been elicited to Ags such as ovalbumin, hen egg lysozyme, cytochrome C and many others, all of which are recognized by antibodies. This is clearly not due to an inability of cd T cells to recognize proteins-in fact, there may be more proteinaceous than non-proteinaceous ligands for the cd TCRs. Nor is it due to an inability of cd T cells to undergo clonal selection following immunization-there are well-documented examples of such selection among peripheral cd T cells. It may have to do, however, with the fact that large portions of the cd TCR are comparatively invariant, and the highly variable area is limited to CDR3d, i.e. one segment of the cd TCR combining site. It seems likely that this particular restriction of variability holds a clue that might eventually help to explain the Ag preferences of cd T cells. 24 
SPECIFIC EXAMPLES OF LIGANDS
The number of bona fide ligands for cd TCRs is still relatively small. Nevertheless, our aim was not to provide a complete list but rather to highlight the differences and diversity of ligands recognized.
MHC-LIKE LIGANDS
Despite the fact that there may be no inherent MHC bias in the cd TCRs-none has been reported as of this writing-MHC molecules were investigated as ligands for the cd TCR even prior to the landmark studies by Matis and Bluestone. 25, 26 The pair of related T-locus Ags, γδT Antigens recognized by γδ T cells Figure 1 cd T cells recognize a wide range of structurally different ligands. Unlike most ab T cells, cd T cells recognize ligands that vary much in size, composition and molecular structure, including MHC and non-MHC cell surface molecules, soluble proteins and smaller peptides, phospholipids, prenyl pyrophosphates and sulfatide. Some of these molecules appear to be recognized in complex with others (e.g. certain phospholipids in complex with CD1d or apo H), and most if not all are recognized while bound to or expressed on the cell surface. apo H, apolipoprotein H; MHC, major histocompatibility complex.
Diverse cd T-cell antigens WK Born et al 14 T10/22, may be considered prototypic, because crystal structures of these Ags, as well as of a cd TCR engaged with T22, have been available for some time now. 27, 28 These structures show that the T Ags do not present peptides, and that the cd TCR (KN6) binds to T22 at an angle, mainly using CDR3d amino-acid side chains for the interaction. This is much unlike the binding of ab TCRs to MHC molecules, where CDR1 and 2 of both TCR-a and b, mainly interact with the MHC surface, and the CDR3s with the peptide in the groove. The repertoire of T10/22 recognizing cd TCRs is diverse, including several Vcs and Vds, with a shared motif in CDR3d (W-(S)EGYEL). 29 Although expressing the motif is sufficient for ligand recognition, these TCRs can have widely different affinities for T22, suggesting that non-motif amino-acid side chains are involved in the interaction as well. Approximately 0.4% of lymphoid cd T cells in mice recognize T22. The biological significance of this specificity remains to be determined. However, because T10/22 appear to be induced by cell stress, it is possible that T10/22-specific cd T cells play a role as monitors of tissue health.
Similarly to T10/22, the classical MHC molecules I-E k,b,s have been identified early as potential ligands for cd T cells. This has been confirmed later in binding studies, which again did not reveal any role for presented peptides. 30 Post-translational modification of these classical MHC molecules appears to be critical for cd T-cell recognition. However, binding affinities are low, the population of murine cd T cells capable of recognizing these ligands remains to be investigated, and the biological role of I-E recognition by cd T cells is still unclear.
Although a number of human cd T-cell lines and clones were characterized early on as MHC-specific, it was not formally shown that their responses were TCR-mediated. This was rectified more recently in the case of a human cd response to HLA B58 (Kaiser A, Fisch P, 5th International cd T cell Conference, 31 May-12 June 2012, Freiburg, GER). Here, it was shown by TCR transfer into a mouse hybridoma cell line that the specific reactivity to the alloantigen HLA B58 is mediated by the cd TCRs, and that this type of recognition supports cytolysis. Interestingly, because the human cd TCR in question differentiates between HLA B*5802 and HLA B*5801, which differ only in three amino acids in the floor of the peptide binding groove, a bound peptide might play a role in this particular case.
Human cd T cells (as well as ab T cells) also recognize group 1 CD1 molecules (CD1a, b, c). 31 These molecules are primarily expressed on professional Ag presenting cells where they present lipid Ags (glycolipids and certain microbial lipids) to the T cells. The Vd1 1 subset of human cd T cells, which is mainly found in the tissues, shows prominent reactivity to CD1c, and produces IFN-c and granulysin in the course of such responses. It has been suggested that the CD1c-reactive cells, dependent in part also on inflammatory cytokines and co-stimulation via NKG2D, provide protection against microbial infections prior to the more slowly developing responses of Ag-specific ab T cells. 31, 32 Finally, it has been reported that group 1 CD1 molecules can present lipid A to human cd T cells. 33 The related group 2 CD1 molecule, CD1d, appears to be recognized by both human and murine cd T cells. [34] [35] [36] [37] The same molecule has been studied in detail as a ligand for classical natural killer T cells, 38 also both in mice and humans. With natural killer T cells, CD1d serves as presenter of certain lipids, and there is some evidence that cd T cells in humans and mice also recognize a CD1d/lipid complex. Thus, cloned human cd T cells responded to phosphatidyl ethanol amine (PE) in a manner dependent on CD1d, which suggested CD1d-restricted recognition of this phospholipid. 34, 35, 39 The phospholipid cardiolipin (CL) binds to CD1d and murine cd T cells responded both in vivo and in vitro to CL dependent on the presence of CD1d, suggesting that this phospholipid is also presented by CD1d, and is thus recognized by the cd T cells. 36 Finally, CD1d appears to present sulfatide, an abundant myelin glycosphingolipid, to human cd T cells expressing Vd1. 40 Thus, the CD1d-restricted recognition by cd T cells of small molecules might be the format closest to MHC-restricted Ag recognition by ab T cells.
The stress-induced MHC class I-related molecules MICA and MICB were also found to be recognized by human cd T cells derived from the intestinal epithelia. These cells expressed diverse Vd1
1 TCRs. Both a1 and a2 domains of MICA/B were involved in the recognition, but Ag processing was not required. 41 Interestingly, the human cd T cells also recognized MIC proteins derived from other primate species despite extensive amino-acid changes in the a1 and a2 domains, perhaps due to a single conserved site. 42 Further examination revealed that MICA/ B are broadly expressed on carcinomas of the lung, breast, kindney, ovary, prostate and colon where they are recognized by tumor-infiltrating Vd1 1 cd T cells, which may affect tumor survival. 43 However, MICA is also a ligand for NKG2D, which is expressed on natural killer cells, CD8
1 ab T cells and cd T cells. All of these cells can be activated via NKG2D, which complicates analysis of the cd responses. 44 MICA engagement by NKG2D also enhances responses of Vc9 1 Vd2 1 cd T cells to non-peptide Ags. 45 Nevertheless, a study with soluble MICA tetramers confirmed binding to Vd1 1 cd TCRs and suggested that MIC delivers both TCR-dependent signal 1 and NKG2D-dependent signal 2 in the appropriate cd T cells. 46 A crystal structure of a MICreactive Vd1 1 cd TCR is now available, revealing a surprisingly flat potential binding surface. Furthermore, it appears that MIC binding by the TCR and by NKG2D is mutually exclusive, perhaps forcing sequential recognition. 47 Finally, a study presented by C. R. Willcox at the 5th International cd T Cell Conference in Freiburg, Germany (31 May-2 June 2012) indicates that the endothelial protein C receptor has joined the ranks of MHC-like cd TCR ligands too. Endothelial protein C receptor is a TCR ligand that is expressed on cytomegalovirus-infected cells and on tumor cells. It is recognized by a human Vc4Vd5 1 clone sensitive to the conformation of the ligand. Recognition-via CDR3-also depends on endothelial protein C receptor expression levels and costimulation, both of which were found to be stress-regulated. This specificity was deemed Ig-like as well.
OTHER PROTEINS EXPRESSED ON THE CELL SURFACE
A study of anti tumor responses by human cd T cells revealed interactions of the Vc9Vd2 cd TCR with an F1-ATPase-related structure expressed on the surface of the Burkitt's lymphoma cell line Daudi and certain other tumor lines but not another Burkitt's lymphoma, Raji. 48 This observation showed that cell surface-expressed proteins other than MHC molecules can be recognized by cd T cells. Moreover, response-inhibitory effects of antibodies directed against a serum protein, apolipoprotein A1, suggested involvement of this protein as well, and this was confirmed in molecular binding experiments using surface plasmon resonance, in which a soluble Vc9Vd2 TCR construct bound both purified F1-ATPase and a delipidated form of apolipoprotein A1. Finally, consistent with the idea that a trimolecular complex of these molecules provides the basis for cd T-cell ligand recognition, apolipoprotein A1 was found to be required for optimal responses of Vc9Vd2 T cells by tumor target cell lines expressing F1-ATPase. Involvement of an apolipoprotein has been observed in another cd response as well 49 and will be further discussed below. Based on other studies, also with Daudi cells, [50] [51] [52] it seems clear that F1-ATPase is not the only non-MHC-related protein on the cell
surface that might be recognized by cd T cells. In fact, screening experiments of murine cell lines and macrophages with soluble cd TCR constructs have implied the presence of multiple additional ligands, 53, 54 although their precise molecular nature remains to be determined.
SOLUBLE PROTEINS
Probably the first defined Ag reported to stimulate specific responses of human cd T cells was tetanus toxoid, a potent immunogen derived from the protein tetanospasmin of Clostridium tetani. 55, 56 Responses included IFN-c production, induction of IL-2R expression and proliferation, and were limited to clones and T-cell somatic hybrids expressing certain cd TCRs. Despite these auspicious beginnings, no further studies on the tetanus toxoid response of cd T cells have been reported and the underlying mechanism remains uncertain.
Further bacterial proteins reported to elicit specific responses of human cd T cells include the unrelated staphylococcal enterotoxin A (SEA) 57 and the toxin listeriolysin O (LLO). 58 Several studies examined the responses of human cd T cells to bacterial super-Ags, such as SEA, SEB, SEE and TSST. 59 Interestingly, Vc9 1 clones killed SEApulsed targets but did not proliferate in response to such stimulation, whereas Vc9-negative cd clones proliferated. The cytotoxic reactivity of the cd T cells was found to be more restricted such that a given clone might respond to SEA but not SEE and vice versa, in contrast to ab T cells, which often respond to multiple SEs. Although limited to certain cd TCRs, binding interactions between SEA or other super-Ags and the cd TCR have not yet been demonstrated, and the analysis of the responses is complicated by observations indicating that some of the cytotoxic activity of the Vc9 1 clones is actually mediated by staphylococcal enterotoxin-specific antibodies that bind to Fc receptors of the cd T cells.
Both rodent and primate cd T cells respond to Listeria monocytogenes. 58, [60] [61] [62] [63] In a study with human cd T cells, live bacteria were required to elicit responses of cd T cells in vitro. A cd T cell line derived from such culture responded specifically to the large LLO-derived peptide LLO 470-508. Since this portion of LLO shows a high degree of homology with other Gram-positive bacterial toxins, it was deemed probable that such toxins might also be recognized. 58 In this system, involvement of the cd TCR remains to be demonstrated. The large size of the stimulatory peptide, which also contains a cysteine, raises the possibility that the LLO-reactive cd T cells might recognize a conformational epitope, but this aspect has not been explored.
Early studies with mycobacterial extracts and purified protein derivative (PPD) revealed responses of human and murine cd T cells to mycobacterial Ags. [64] [65] [66] The murine response to PPD was found to be limited to cells expressing Vc1, 67 suggesting cd TCR involvement in the response to a mycobacterial protein molecule. Nevertheless, subsequent studies with human cd T cells focused on non-peptidic Ags contained within but not specific to mycobacteria (see below). More recently, defined mycobacterial proteins were also found to elicit cd Tcell responses. One of these is ESAT-6, a small, highly immunogenic protein, which is part of a transmembrane secretion pathway in M. tuberculosis, 68 and a critical virulence factor. 69 A response to ESAT-6 was initially observed in cd T cells of cattle experimentally infected with M. bovis.
WC1
1 bovine cd T cells responded to this protein with proliferation and IFN-c secretion and changes in CD45 isoforms. 71, 72 A cd response to ESAT-6 was also observed in patients with active pulmonary tuberculosis. 73 Others reported that ESAT-6 directly induces purified cd T effector memory cells from tuberculin skin testpositive patients to produce IFN-c, and that CD4 1 ab T cells regulate this response. 74 However, this observation has been challenged and it requires further investigation. 75, 76 Since ab T cells also respond to ESAT-6, and for possible application in a tuberculosis vaccine, 77 it will be important to show that an ab T cell-independent cd response exists.
cd T cells protect mice from herpes simplex virus (HSV) type 1-induced lethal encephalitis, 78 and cd T cells were isolated that recognize and respond to HSV glycoprotein 1. 79 Further characterization of a clone expressing Vc2Vd8 revealed that this response does not require classical Ag-processing pathways and in fact can occur in the absence of any APCs, 80 similar to the findings with small peptide Ags described below. 19, 81 The HSV glycoprotein 1-reactive cd clone responded in a B cell-like manner to a conformational epitope, and it did not require any glycosylation of the Ag. The epitope was localized to the solventexposed amino terminus of the protein, and it was sensitive to sulfhydryl reduction. 82 The same clone failed to respond to glycoprotein 1 derived from HSV-2, suggesting that amino acid differences near the N-terminus and specific to these orthologues are critical for recognition. 79 These data provided convincing evidence that soluble non-MHC proteins can be recognized by cd T cells and suggest that such reactivity might play an important role in host protection against viral infections.
83
In a study of anti-tumor responses by human T cells, TCR-d 1 cytotoxic cells with specificity for an immunoglobulin idiotype of autologous B-cell tumors were detected. 84 Further investigation showed that the cd CTLs specifically recognized the l light-chain protein. 85 However, the anti-tumor response was not inhibited by l-specific antibodies, and cells transfected with a l-chain construct that could not be expressed on the cell surface were still lysed suggesting that the cytolytic cd T cells recognized the l-protein in a processed form. There was no indication of MHC-mediated Ag presentation, but because antibodies against a member of the HSP-70 family, which is expressed on the surface of the target cells, inhibited the anti tumor response, the authors suggested that l might be recognized by the cytolytic cd T cells in the form of an HSP-70-presented peptide Ag. Despite such intriguing findings, no further reports on this response have appeared. The postulated antigenic l peptide has not been confirmed, and it remains unclear if the l protein needs to retain some secondary structure to be recognized. Ig l contains several cysteines, and in view of the studies with HSV gI, 82 as well as our own recent observations with an insulin peptide (Kemal Aydintug M, unpublished, see below), it might be worthwhile to determine whether the redox state of the l-chain influences its antigenicity.
Most recently, the target specificity of a human cd TCR derived from a presumed autoreactive and pathogenic cd T-cell clone has been determined. This amazing story goes back to a rare case of human autoimmune myositis where infiltration of skeletal muscle with cd T cells instead of the more common autoreactive ab T cells was observed. 5 It was found that the muscle-infiltrating cd T cells were clonally expanded and express an uncommon Vc1.3Vd2 1 cd TCR. 86 Based on responses of transfectomas, as well as binding studies with soluble TCR constructs, 87, 88 it appears now that this cd TCR (named M88) recognizes a common conformational motif on the surface of several proteins from different species, including bacterial and human aminoacyl-tRNA synthetases. 89 For example, M88 recognizes histidyltRNA synthetase, which is also targeted by autoantibodies in patients with myositis. One of the soluble proteins recognized, the E. coli translation initition factor 1, has been mutagenized extensively to show that a short a-helical stretch including amino acids 39-42 of the E. coli translation initition factor 1 constitutes a critical part of the epitope for
M88. Several aspects of this response seem noteworthy including the focus of a cd TCR on a conformational epitope, which is reminiscent of the findings with HSV glycoprotein 1, 82 the multispecificity of the cd TCR, which recognizes an epitope shared between various unrelated proteins, and the convergence of cd and antibody responses, which focus on the same Ags.
SMALLER PEPTIDES
In addition to the cd responses to intact native proteins, a number of responses to smaller peptide Ags have been reported as well. These have been listed elsewhere in greater detail. 90 Briefly, using hybridomas with murine cd T cells, responses to peptides as short as seven amino acids were observed. 91 The first report of a response to a small, defined peptide Ag involved a peptide derived from a mycobacterial heat shock protein, HSP-65. 81 The peptide (p180-196) was recognized by a large number of clones expressing murine Vc1, 92 and it was shown by TCR transfer that the hybridoma response was TCRdependent. 91 Unlike ab T cells recognizing small peptides in an MHC-restricted fashion, cd hybridomas responding to these peptides did not require APCs, 92 in this regard resembling B cells. Because the shortest HSP-derived stimulatory peptide (FGLQLEL) resembled a motif shared by unfolded proteins which bind to the molecular chaperone HSP-70 BiP, 93 we also examined unrelated peptides having this motif for their ability to elicit cd responses. Several were stimulatory, albeit not as strongly as the HSP peptide (data unpublished). Although we have previously suggested that this might reflect an ability of cd T cells to recognize unfolded proteins, it might instead indicate that cd T cells recognize, rather than singular aminoacid sequences, secondary structure of peptides such as, for example, a helices.
More recently, we have studied a different peptide response of murine cd T cells involving a major insulin epitope in the non-obese diabetic mouse model of type 1 autoimmune diabetes. The Ins2 B:9-23 peptide is a naturally occurring Ag contained in certain b cells of the pancreatic islets, 94 which is recognized by diabetogenic I-Ag 7 -restricted CD4
1 ab T cells, and by B lymphocytes. 95 In a hybridoma collection generated to screen the TCR-Vb repertoire of B:9-23 peptide-reactive ab T cells, a peptide-reactive clone was found expressing a cd TCR. 19 This hybridoma (SP9D11) expressed Vc4 paired with Vd10. In addition to the peptide, the hybridoma responded to a preparation of pancreatic islet cells, but not to intact insulin. The peptide response was TCR-dependent and, like the cd hybridomas recognizing HSP-65-derived peptides, SP9D11 did not require APCs, unlike all B:9-23-reactive ab T cells. In fact, the cd response did not require any accessory cells, because isolated individual SP9D11 hybridoma cells still responded to the peptide when tested in a single-cell assay. 19 Unlike cd cells recognizing HSP-derived peptides, the repertoire of B:9-23-reactive cd T cells includes different Vcs in addition to several Vds. Thus, different portions of the cd TCR might be critical in recognizing the insulin peptide Ag. Whereas two C-terminal amino acids of the insulin peptide appear to be dispensable for the cd response, the Nterminal one is required. Surprisingly, the cd response also required the tyrosine in position 16, in this regard resembling I-Ag 7 -restricted ab T cells. However, in contrast to the ab T cells, cd cells also require the cysteine in position 19, 19 suggesting that the peptide might be stimulatory as a dimer. This was recently confirmed (Kemal Aydintug M, manuscript in preparation). It is also noteworthy that B:9-23 represents an a-helical segment of the insulin B chain. Some of this secondary structure might be retained by the peptide and could be important for cd recognition.
Several other defined peptides have been either implied as Ag for cd T cells or actually found to be stimulatory, including the already mentioned processed Ig l light-chain protein, 85 a peptide derived from tetanus toxin (C. tetani, 1235-1246) 96 and a LLO-derived peptide (470-508). 58 However, the molecular details of these responses remain to be determined.
Finally, some studies involving random heterocopolymers of two or more amino acids have been reported as well. Most prominently, a response of a cd hybridoma to poly GT, a polymer of approximately 100 amino acids containing glutamic acid and tyrosine at a 1 : 1 ratio, was published as early as 1989. 97 We later showed that essentially all Vc1 1 cd T cells respond to poly GT, 18 as well as cells expressing other cd TCRs, but we were unable to confirm the original claim that poly GT is recognized in the context of Qa-1 b . With its random sequence, poly GT is not a defined Ag and does not have a defined structure. However, it seems probable that segments of individual pGT molecules assume secondary structures, some of which might meet stimulatory requirements. pGT is also anionic, and we have pointed out before that several polyanionic structures are capable of stimulating Vc1 responses, perhaps due to particular properties of Vc1 itself. 16 
NON-PEPTIDIC AGS
Original observations that large numbers of cd T cells were responsive to mycobacteria and mycobacterial Ags included both human and murine cells. [64] [65] [66] 98 However, while many murine cells were found to react with mycobacterial PPD and HSP-65, 66 human mycobacteriareactive cd T cells failed to react with PPD and HSP-65. 99 Searching for alternative Ags, Pfeffer and colleagues 100 found that most human mycobacteria-reactive cd T cells responded to Ags contained in fractions of mycobacterial lysates with a molecular mass of ,3 kDa. Moreover, these Ags were protease-resistant. In contrast, only few human cd T cells responded to PPD and HSP-65. These surprising observations were rapidly followed by studies identifying several mycobacterial and synthetic non-peptidic Ags for human cd T cells, first the mycobacteria-derived TUBag4, a 59 triphosphorylated thymidine-containing compound with additional structurally related stimulatory molecules 101 and then synthetic alkyl phosphates. In particular monoethyl phosphate, 102 and subsequently mycobacteriaderived isopentenyl pyrophosphate and related prenyl pyrophosphate derivatives were found to be stimulatory. 103 Since these early reports, many additional Ags of essentially the same type, now often somewhat imprecisely referred to as 'phosphoantigens', have been described. Although some are only weak stimulators, others were found that are extremely potent, most prominently perhaps HMBPP, 104 a metabolite in the 2-C-methyl-D-erythritol-4 pathway for isoprenoid synthesis.
Despite their small size, recognition of the prenyl pyrophosphates by the Vc9Vd2 cd TCRs depends on all CDRs. 105 This may be more understandable considering that these small molecules appear to be presented on the surface of target cells 17, 106, 107 and thus might be 'seen' in a certain context. However, the mechanism of presentation remains mostly unclear, and it might vary between individual Ags.
Finally, there are small molecular compounds that stimulate prenyl pyrophosphate-reactive cd T cells indirectly, by blocking farnesyl pyrophosphate synthase in the mevalonate pathway, which increases cellular IPP levels. 108, 109 These include bisphosphonates 110 and alkylamines. 111 It should be noted that the response to prenyl pyrophosphates is limited to a single subset of cd T cells present in primates, both human and non-human. This response already received and clearly deserves Diverse cd T-cell antigens WK Born et al 17 much attention, because of its potential therapeutic significance and because so many human peripheral blood cd T cells show this specificity, but there is no indication that it is representative of cd specificities in general.
PHOSPHOLIPIDS
In the 1990s, our lab used a collection of hybridomas generated with cd T cells from normal untreated mice to screen for ligands recognized by the cd TCR. Because we had already found responses to other anionic molecules (oligonucleotides and peptides), we also tested anionic phospholipids. We promptly found TCR-dependent responses to CL and the related phospholipids phosphatidylglycerol and phosphatidic acid, but not to other phospholipids (phosphatidylinositol, phosphatidylserine, phosphatidylcholine and phosphorylcholine). Only cells expressing Vc1 responded, and the response was dependent on the presence of a serum factor, which we tentatively identified as apolipoprotein H (apo H, b 2 -glycoprotein 1). These findings suggested a connection with numerous observations made with so-called antiphospholipid antibodies, which develop in response to some infections but also in patients suffering from autoimmune diseases. Some such antibodies react with apo H, or complexes of apo H and CL. 112 Because the cd cells required CL and serum factors in stoichiometric ratios in order to respond optimally, we suggested that they might recognize CL and apo H in a complex as do antiphospholipid antibodies. 49 This remains to be confirmed, however. Although we observed anti CL responses only with hybridomas, recently another group reported that normal splenic and hepatic cd T cells from healthy mice proliferated in vitro in response to CL. Such cells were also activated in vivo following transfer of CL-pulsed dendritic cells and here, they noted a requirement for CD1d expression by the DC. They finally demonstrated that CL binds to CD1d and provided a crystal structure of this complex. 36 They suggested that cd T cells can recognize this complex but further analysis will be required to confirm this proposed mechanism.
Human cd T cells were reported to recognize PE, apparently also in the context of (human) CD1d. 35 The investigators found that cloned peripheral blood or nasal mucosa-derived cd T cells from cypress pollen-sensitive subjects responded to pollen-derived PE after incubation in vitro. The response was specific for PE and limited to molecules with partially saturated fatty acid side chains. In a subsequent study, the same group found that human cd T cells derived from the duodenal mucosa also contained a high percentage of CD1d-restricted PEreactive cd T cells. 39 Taken together, the studies of three independent groups involving mice and humans make a good case that phospholipids also belong into the category of ligands recognized by cd T cells.
Finally, a just published study already mentioned above indicates that the myelin-derived glycosphingolipid sulfatide is also recognized, by human Vd1 1 cd T cells. 40 This new observation hints at the possibility of other not yet identified categories of non-peptidic Ags for cd T cells.
DISTRIBUTION OF cd T-CELL SPECIFICITIES
Despite an enormous potential for receptor diversity in CDR3d, 3 clear evidence of peripheral selection of cd T cells 6 and the occasional emergence of cd T-cell clones, 5 most specificities identified so far are not clone-specific. It is not clear whether this is mainly a bias of the investigators-polyclonal responses are more easily spotted-or an intrinsic property of cd T-cell recognition. The response to poly GT in mice, for example, is shared by Vc1 1 cells, Vc2 1 cells and others. Similarly, the response to PPD is common to most Vc1 1 cells. It could be argued that these examples are inadequate because both stimuli are composed of a heterogeneous mix of molecules, but the response to a fully defined peptide (HSP-65 p180-196) was also shared by most Vc1 1 cells. Similarly, many Vc1 1 cells respond to CL, and all of these responses are demonstrably TCR-dependent. In contrast to these responses, the insulin peptide B:9-23 is recognized by some cd T cells expressing Vc4, but also by some expressing Vc1 and by others expressing at least one additional Vc. B:9-23 reactive cd T cells seem to be frequent in the non-obese diabetic mouse strain but not in C57BL/6 mice, but this needs to be confirmed. The much studied response to T10/22 is shared by many different cells expressing the TCR-d CDR3 motif W(S)EGYEL, which is largely based on one reading frame of Dd2, in murine cd T cells expressing several different Vcs and Vds. In humans, the responses to prenyl pyrophosphates are shared by many Vc9Vd2 1 cells, with only some bias for particular c-chain CDR3 amino acids, 105 and many Vd1 1 cells respond to MICA/B. However, the recognition by a polymyositis associated cd TCR of a peptide motif on amino-acyl tRNA synthetases is remarkable because the TCR is derived from clonally expanded cd T cells, and both CDR3s seem to play a role. Here, the cd TCR seems to provide specificity for a conformational motif shared by a number of related and some unrelated proteins. Albeit still sketchy, these data taken together suggest that ligand recognition by cd T cells can occur in different modes, e.g. involving none, one or two CDR3s, and specificities might be distributed over larger and smaller subsets of cd T cells, depending on the Ag. A logical consequence of this is that many individual cd T cells are multispecific. Indeed, this is what we find. For example, a single murine cd TCR expressed by a hybridoma clone might support responses to poly GT, PPD, HSP-60 p180-196 and CL. Over the years, we observed several cells with such broad reactivity pattern. More interestingly, perhaps, we recently found that a cell that recognizes T22, because it expresses the appropriate CDR3d motif also responded to pGT and even to the insulin peptide B:9-23 (Kemal Aydintug M, unpubl. observ.). However, it seems that some cd T cells are more likely to be multispecific than others. In mice, Vc1 1 cd T cells seem to have a greater propensity for multispecificity than Vc4 1 or Vc6 1 cells. In this regard, Vc1 1 cells in mice are reminiscent of the polyspecific B1 B cells. In humans, multispecific cd T cell clones have been observed as well, mostly with Vc9Vd2 1 cells. Here, mycobacteria-reactive cells also might respond to tetanus toxoid, to non-mycobacteria-derived phosphoantigens, or to phospholipids in the context of CD1d.
CONSEQUENCES OF MULTI-SPECIFICITY
With all multispecific lymphocytes, the question of self-tolerance looms heavily. Selection becomes more complex if there are several specificities of auto-Ags within one responder. Negative selection of high affinity clones also removes their low affinity specificities as well as possible specificities for non-self Ags. A requirement for intermediate to low affinities for several Ags might diminish a large cell population to a small one that fits all the selection criteria. On the other hand, surviving multispecific cells might be more useful than monospecific ones, simply because they can be employed in several different settings. Moreover, as has been argued before, specificities shared by many cd T cells would make for faster responses by eliminating the need for prior clonal expansion.
CONCLUSIONS
A review of the Ags recognized by cd T cells reveals a remarkable diversity (Figure 1 ). This likely precludes a single mechanism of ligand recognition akin to that of MHC-restricted ab T cells, but does not 
